<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Upaasana Muppidi on Medium]]></title>
        <description><![CDATA[Stories by Upaasana Muppidi on Medium]]></description>
        <link>https://medium.com/@urmuppidi?source=rss-fe689d580173------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/0*E0LQueLQipgu9N4t</url>
            <title>Stories by Upaasana Muppidi on Medium</title>
            <link>https://medium.com/@urmuppidi?source=rss-fe689d580173------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sat, 21 Nov 2026 09:19:56 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@urmuppidi/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[What if Nanny could Think?]]></title>
            <link>https://medium.com/@urmuppidi/what-if-nanny-could-think-5ec36349deb2?source=rss-fe689d580173------2</link>
            <guid isPermaLink="false">https://medium.com/p/5ec36349deb2</guid>
            <category><![CDATA[biotechnology]]></category>
            <category><![CDATA[questions]]></category>
            <category><![CDATA[alzheimers]]></category>
            <category><![CDATA[nanotechnology]]></category>
            <category><![CDATA[neuroscience]]></category>
            <dc:creator><![CDATA[Upaasana Muppidi]]></dc:creator>
            <pubDate>Sat, 22 Aug 2026 00:03:11 GMT</pubDate>
            <atom:updated>2026-08-22T00:03:11.345Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/282/1*pPiNiGEGXhNKVIxU7f-3wQ.png" /></figure><p>As a child, I would wonder why I could remember the names of most Pokemon but couldn’t remember how to differentiate between my right and left despite asking my Mom about it earlier that day. I would wonder why I had dreams and my parents didn’t. I would wonder why it seemed like my Mom and Dad knew everything about the world, yet I didn’t. There would mostly be a clear answer to my questions, but sometimes the search result was simply that there wasn’t enough information to know why and how certain things happen. It felt frustrating getting no results; if the brain is supposed to be involved in so many processes, why is there so little known about the way it operates? Its mysteriousness made it intriguing to me.</p><p>It feels like those initial experiences with the brain are what led to my prolonged interest with it.</p><p>Since then, I stumbled upon Alzheimer’s Disease and learned about how certain genes can influence one’s chances of having it. It was shocking to discover that the apoE4 allele in particular increased development by two to three times with one copy and eight to fifteen times with two copies. It just seemed so unfair, especially when memories mean so much to us. That’s why I started working on <a href="https://medium.com/@urmuppidi/preventing-alzheimers-before-it-strikes-5ef2e3de5c7b">Nanny the Nanobot</a>. It could combat this gene by preventing, or at least minimizing the damage from, the development of Alzheimer’s Disease in individuals with the genetic disadvantage through strategies such as stopping amyloid-beta monomers from forming plaques and by targeting and observing the salt bridge between Glu255 and Arg61.</p><p>It is imperative that we try to save our brains and the foundation that makes us who we are as people.</p><p>What if Nanny could receive the gift of having its own brain? By that, I mean to talk about Nanny being able to make its own decisions. Instead of following preset rules, Nanny could be autonomous;it would sense stimuli, evaluate it with the help of a large database, decide how to react, and act upon that. Of course, this would all be with certain restraints. Guardrails would be put in place to restrict what Nanny can interact with, actions it could take, when it could act, and when to stop.</p><p>I have started exploring the idea of building Nanny’s brain using quantum computing. It could be built with <a href="https://pennylane.ai/">PennyLane.</a> As I was thinking about how Nanny would function, I realized I could either let it follow a strict guideline where it does its job exactly how it is programmed to do so, or I could let Nanny figure out what strategy to employ from its observations. With human bodies being so different from each other, requiring different treatments, and needing unique care and attention, the latter seemed like the obvious choice. This is why I want to pursue the integration of quantum computing into Nanny.</p><p>Quantum computing is normally associated with big machines in special facilities, but what if it didn’t have to stay there? What if it could travel with Nanny instead of being regulated externally? This would be scalable with a quantum chip such as <a href="https://www.livescience.com/technology/quantum/scientists-built-a-room-temperature-quantum-computer-with-diamond-based-qubits">the one recently developed by Saxon Q</a> with a latest accuracy rate of 99.98%.</p><p>A portable chip has less error, does not need specialized, expensive cooling, and is not restricted in location compared to computers in labs. Also, while quantum supercomputers may complete computations faster, they need added time for information to be sent to a server and back, meaning time is not a significant drawback.</p><p>Saxon Q’s chip uses sulfur-implanted diamonds with nitrogen-vacancy centers. Normal diamonds have carbon making up most of their lattice, however some diamonds exist with a missing carbon atom and a nitrogen atom replacing a carbon atom. Natural existing diamonds with this defect are rare, so most are lab-grown. This nitrogen vacancy center’s controllable spin state is used as a qubit, giving quantum information. Initially, lasers set the state of nitrogen atoms’ electrons to be measured as 0. Microwave pulses are then used to manipulate electrons into different arrangements. Implanting sulfur into the diamond makes the nitrogen-vacancy center more negatively charged due to electrons being donated, allowing the center to be easier to manipulate.</p><p>I want to explore building a design that would eventually allow Nanny to move beyond preset instructions. If quantum allows Nanny to process information and operate within specific parameters, it is what I believe should be applied into Nanny’s decision-making system.</p><p>Years after wondering how my brain works the way it does, I find myself asking a new question: can we use our brains to build systems that can preserve what makes us who we are as people?</p><p>I think we can, and I hope you believe in that possibility as well.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*UCBI5eRVXhL7sUmRine1mA.jpeg" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5ec36349deb2" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[What Nanny can Learn from ALZ-801]]></title>
            <link>https://medium.com/@urmuppidi/what-nanny-can-learn-from-alz-801-f9a8887e8989?source=rss-fe689d580173------2</link>
            <guid isPermaLink="false">https://medium.com/p/f9a8887e8989</guid>
            <category><![CDATA[science]]></category>
            <category><![CDATA[neuroscience]]></category>
            <category><![CDATA[nanotechnology]]></category>
            <dc:creator><![CDATA[Upaasana Muppidi]]></dc:creator>
            <pubDate>Thu, 11 Jun 2026 23:37:45 GMT</pubDate>
            <atom:updated>2026-06-11T23:37:45.144Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/410/1*KWTvqEqB6iVLbJfRASrWBQ.png" /></figure><p>ALZ-801, a pill developed by <a href="https://www.alzforum.org/therapeutics/alz-801">Alzheon</a>, proves to be a promising preventative medicine that slows down the progression of Alzheimer’s disease. Rather than targeting amyloid-beta oligomers that are already built up in the brain, ALZ-801 aims to prevent their formation. Since these plaques are known to damage neurons and disrupt their communication, preventing their formation can slow the progression of Alzheimer’s Disease. The pill is created by linking valine to tramiprosate, producing a compound known as valinetramiprosate.</p><p>Once in the brain, ALZ-801 surrounds amyloid monomers and stabilizes their shape by binding with them. This prevents protein misfolding, a common development in people with Alzheimer’s Disease. They are stopped from clumping together and forming plaques.</p><p>Another important aspect of ALZ-801 is the fact that it is not toxic to the brain. Side effects such as brain swelling and brain bleeds are very common in other Alzheimer’s therapies. ALZ-801 only interacts with amyloid-beta plaques. This has resulted in studies showing no harm to the brain while taking ALZ-801. The drug also metabolizes into 3-sulfopropanoic acid, which is already found in the brain. Since the body is already exposed to this molecule, the chemical formula has no significant effect on the body.</p><p>My <a href="https://medium.com/@urmuppidi/preventing-alzheimers-before-it-strikes-5ef2e3de5c7b">Nanny the Nanobot</a> can take some inspiration from ALZ-801 through its similar preventative strategy. It can prioritize nontoxicness to neurons and the targeting of amyloid-beta through enveloping it rather than aggressively attacking it. Nanny could focus on stabilizing and isolating amyloid monomers before they can aggregate into toxic oligomers. This would minimize side effects while effectively targeting amyloid-beta. Likewise, instead of relying on invasive plaque removal, Nanny the Nanobot could support natural processes that remove waste particles, so the method of opposing amyloid-beta plaques is a lot easier for the body to contain. It could guide amyloid-beta to natural clearance pathways such as the glymphatic system so that monomers and existing oligomers can exit safely.</p><p>While it is still in phase-3 clinical development, ALZ-801’s newer approach to dealing with Alzheimer’s Disease proves to be a promising strategy that demonstrates how preventing protein aggregation could be more effective than removing formed amyloid-beta clusters.</p><p>Nanny shares this strategy, with the belief that the future of treatment lies in the prevention of Alzheimer’s Disease rather than the reversal of damage.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/674/1*WmW9ZogVkx4amtre-l0adA.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f9a8887e8989" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Small Molecule Correctors]]></title>
            <link>https://medium.com/@urmuppidi/small-molecule-correctors-e609257c7224?source=rss-fe689d580173------2</link>
            <guid isPermaLink="false">https://medium.com/p/e609257c7224</guid>
            <category><![CDATA[alzheimers]]></category>
            <category><![CDATA[nanotechnology]]></category>
            <category><![CDATA[science]]></category>
            <category><![CDATA[neuroscience]]></category>
            <dc:creator><![CDATA[Upaasana Muppidi]]></dc:creator>
            <pubDate>Thu, 09 Apr 2026 23:22:54 GMT</pubDate>
            <atom:updated>2026-04-09T23:22:54.722Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/480/1*G_2Bf6d01phj8PfEkgtqKQ.png" /></figure><p>Alzheimer’s Disease remains as challenging to treat and understand as ever, affecting millions worldwide. While many approaches focus on managing symptoms or removing protein buildup, not many strategies directly address the structural causes behind the disease.</p><p>While exploring different strategies that <a href="https://medium.com/@urmuppidi/preventing-alzheimers-before-it-strikes-5ef2e3de5c7b">Nanny the Nanobot</a> could employ, I decided to step back from focusing on the <a href="https://medium.com/@urmuppidi/breaking-the-bridge-0ad349ac6614">removal of the salt bridge</a> between Arg61 and Glu255 and instead considered alternative ways to alter apoE4’s closed, flawed structure. This shift in research allowed me to come across “small molecule structure correctors”; these compounds are designed to target its abnormal shape at a structural level. As previously discussed, the interaction between Arg-61 and Glu-255 brings the amino-terminal and carboxyl-terminal domains closer together and allows for interaction, causing apoE4 to have a more compact conformation than apoE3.</p><p>This structural difference is not something one can easily overlook as harmless. It is what drives many of the negative effects associated with apoE4. Through its design, apoE4 generates toxic neurofragments, contributes to mitochondrial dysfunction, and has impaired lipid transport. To make things worse, apoE4 promotes amyloid-beta aggregation and has a reduced ability to clear it, greatly contributing to neurodegeneration.</p><p>To combat this, researchers have developed small molecule structure correctors. Small molecule correctors block the domain interaction in apoE4. They do this by specifically disrupting the interaction between Arg-61 and Glu-255. This prevents the amino and carboxyl terminals from being so close and alters the structure of apoE4 to be more open like apoE3.</p><p>Several compounds have demonstrated these effects in apoE4. For example, <a href="https://pubmed.ncbi.nlm.nih.gov/22158868/">CB9032258</a> inhibits the domain interaction and has been proven to restore mitochondrial cytochrome c oxidase subunit 1 levels(facilitates oxygen reduction), improve mitochondrial transport and positioning, and promote neurite outgrowth in cells. These benefits show how precise the structure correctors are. Other compounds, like GIND-105 and GIND-25 also can change the structure of apoE4 so it more closely resembles apoE3. While still in preclinical trials, a new class of structure correctors called <a href="https://escholarship.org/content/qt01p8x6df/qt01p8x6df.pdf">pyrazoline analogs</a> are also a promising choice for Nanny to use. They bind to and stabilize the N-terminal domain to prevent interaction between Arg-61 and Glu-255 by reducing the electrostatic interaction between them.</p><p>Small molecule correctors also restore normal cellular processing in apoE4. ApoE4 is generally targeted for degradation instead of secretion, but it can have normal Golgi-ER trafficking through structure correctors. Structure-correctors target the neuronal secretory pathway that was previously impaired by apoE4’s abnormal movement; they are able to restore transit in the endoplasmic reticulum and golgi apparatus. By stabilizing apoE4, it can move more normally through these organelles. This improves protein handling and reduces the formation of harmful byproducts. One of the most damaging effects of apoE4’s abnormal structure is the generation of neurotoxic fragments from carboxyl-terminal 27–30 amino acids. They escape the secretory pathway and enter the cytosol where they target the mitochondria; causing mitochondrial dysfunction, altering the cytoskeleton, and enhancing tau phosphorylation; and making it detach, misfold, and aggregate into neurofibrillary tangles.</p><p>By blocking domain interaction, small molecule correctors decrease the amount of fragments produced by 20–25%!</p><p>Given these positive effects, Nanny the Nanobot could integrate the use of similar small molecule correctors directly in the brain to target neurons expressing apoE4. This would target the problems the harmful protein caused by changing it at the structural level.</p><p>Treating apoE4 at this level represents how Alzheimer’s disease can be approached in newer, more innovative ways and target causes instead of just treating the effects. Reshaping apoE4 into a less harmful form offers hope to the millions fighting its development and shows how this field’s progress.</p><p>Keeping in mind that is just one possible solution for addressing a removal of the salt bridge between Arg-61 and Glu-255, it is a very promising one. Opening up apoE4 could open up new possibilities in how Alzheimer’s Disease is perceived. No longer will it be looked at as confusing and a lost cause. Pairing small molecule correctors with Nanny the Nanobot represents a compelling step forward into the fight with Alzheimer’s Disease.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/282/1*y5b-ktx3g4wDrt-Up4trew.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e609257c7224" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Crossing the BBB]]></title>
            <link>https://medium.com/@urmuppidi/crossing-the-bbb-5728dc07c8b0?source=rss-fe689d580173------2</link>
            <guid isPermaLink="false">https://medium.com/p/5728dc07c8b0</guid>
            <category><![CDATA[nanotechnology]]></category>
            <category><![CDATA[technology]]></category>
            <category><![CDATA[alzheimers]]></category>
            <category><![CDATA[neuroscience]]></category>
            <dc:creator><![CDATA[Upaasana Muppidi]]></dc:creator>
            <pubDate>Fri, 06 Mar 2026 00:38:09 GMT</pubDate>
            <atom:updated>2026-03-06T00:38:09.333Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/354/1*Ylk9f5D3lCkHIi5vo1srXg.png" /></figure><p>In order to reach the brain, Nanny has to overcome a few hurdles.</p><p>Protecting the brain is the blood-brain barrier, a defensive structure lined with endothelial cells connected by tight junctions of occludins, claudins, and junction adhesion molecules. These tight junctions prevent foreign substances from entering the brain. Although this protection is essential for survival, it creates a major obstacle for my Nanny the Nanobot. For Nanny to do <a href="https://medium.com/@urmuppidi/preventing-alzheimers-before-it-strikes-5ef2e3de5c7b">its job</a>, it first has to make it across this tightly controlled system.</p><p>To overcome this challenge, Nanny’s nanoparticles will likely be engineered to be cationic. One way Nanny could cross the barrier is through a process called adsorptive-mediated transcytosis as introduced by <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9032478/">Andrew M Hersh, Safwan Alomari, and Betty M Tyler.</a> This process relies on electrostatic interaction between cationic nanoparticles and the anionic endothelial cells lining the BBB. These interactions allow the nanoparticles to be taken up and transported across the endothelial cells. After crossing the barrier, Nanny would then diffuse through extracellular space to reach its target.</p><p>To further increase targeting efficiency, the nanoparticles can be coated with ligands that bind to receptors found in target regions. For example, the nanoparticles could be coated in insulin for increased chances of ending up near the hippocampus, which contains a high density of insulin receptors. Since nanoparticles tend to accumulate in areas where their corresponding receptors are found in abundance, this strategy increases the probability of successful delivery. This strategy can be applied while keeping in mind that the ligand coating cannot be too dense in order to avoid reducing Nanny’s ability to cross the BBB efficiently.</p><p>Nanny could be coated with polyethylene glycol to improve chances for interaction and increase circulation time with endothelial cells. PEG “hides” nanoparticles from the immune system and reduces inflammatory responses from the microglia, allowing Nanny to remain in the bloodstream longer.</p><p>Another option is utilizing transferrin-mediated transport. Transferrin naturally transports iron across the BBB and undergoes receptor-mediated endocytosis by binding to transferrin receptors. By coating nanoparticles in transferrin, Nanny could exploit this pathway to cross the barrier.</p><p>While these approaches show promise, successful BBB crossing requires a balance between efficiency and safety. Positively charged nanoparticles in the brain can stimulate the formation of a reactive oxygen species which may damage surrounding cells.</p><p>Transport must be optimized to allow crossing while minimizing potential toxicity.</p><p>While the blood-brain barrier presents a significant obstacle, combining receptor targeting, charge engineering, and protective coatings will make it possible for Nanny to cross the BBB, remove the <a href="https://medium.com/@urmuppidi/breaking-the-bridge-0ad349ac6614">salt bridge between Glu255 and Arg61</a>, and ultimately reach its destination to prevent the development of Alzheimer’s disease. Overcoming this obstacle brings us a step closer to a future where people with ApoE4 no longer have to worry about if they’ll forget everything.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/642/1*riZk4r8-ET7hn4KBFUF_lw.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5728dc07c8b0" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Inspiration from ApoE2]]></title>
            <link>https://medium.com/@urmuppidi/inspiration-from-apoe2-43c89dd3cf2c?source=rss-fe689d580173------2</link>
            <guid isPermaLink="false">https://medium.com/p/43c89dd3cf2c</guid>
            <category><![CDATA[neuroscience]]></category>
            <category><![CDATA[alzheimers]]></category>
            <category><![CDATA[nanotechnology]]></category>
            <dc:creator><![CDATA[Upaasana Muppidi]]></dc:creator>
            <pubDate>Fri, 30 Jan 2026 00:07:07 GMT</pubDate>
            <atom:updated>2026-01-30T00:07:07.119Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/368/1*eNvbJpnij19LURA2O7JcTw.png" /></figure><p>What if Nanny the Nanobot could actively protect someone from Alzheimer’s Disease instead of just reducing one’s risk of having it?</p><p>There is only around a 0.4% chance of developing Alzheimer’s Disease with the ApoE2 allele. With two copies of ApoE4, there is a 60% chance of developing it. Even worse, more than 50% of people with Alzheimer’s have the ApoE4 gene. This raises the question: how does a person’s ApoE genotype so strongly influence their likelihood of developing Alzheimer’s Disease?</p><p>A primary reason for this difference is ApoE2’s enhanced ability to promote amyloid-beta efflux across the BBB and reduce the amyloid-beta plaque buildups that would interrupt synaptic communication. ApoE4 has an impaired ability to perform amyloid-beta efflux and allows the buildup of amyloid-beta plaques. ApoE2 uses LRP1 receptors along with VLDLR to clear amyloid-beta. It acts much quicker compared to the solely VLDLR-controlled pathways ApoE4 uses instead. ApoE4 prefers VLDL receptors because of its compact shape. This is because of the N and C terminal domain interactions allowed by the salt bridge from Arg61 and Glu255, as discussed in <a href="https://medium.com/@urmuppidi/breaking-the-bridge-0ad349ac6614">my previous article</a>, that contribute to the shape of the protein.</p><p>One possibility is Nanny helping ApoE4 with the removal of amyloid-beta plaques by binding to amyloid-beta and transporting it out of the brain. This is how LRP1 receptors remove amyloid-beta. Another, and the most likely solution, is the removal of the salt bridge between Glu255 and Arg61. This would change the shape of the ApoE4 protein and make it less compact because of the lack of N and C terminal domain interactions. This could make ApoE4 prefer LRP1 receptors and make the clearance of amyloid-beta much quicker.</p><p>Ultimately, Nanny the Nanobot allows you to take control of your body, rather than letting your problems be decided by genetics. Nanny will bind to and remove the salt bridge from Glu255 and Arg61; doing this changes the ApoE4’s structure to one more like ApoE2. Nanny would make amyloid-beta clearance more efficient. It can continue to assist with the removal of amyloid-beta as needed. Additionally, a temporary structural modification may be preferable because it doesn’t interfere with the protein’s long-term function and cause unpredictable side effects.</p><p>Nanny represents a shift from managing AD after damage occurs, to preventing its development altogether.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/452/1*uDpOCEKeY58MmMuNFiyzyw.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=43c89dd3cf2c" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Breaking the Bridge]]></title>
            <link>https://medium.com/@urmuppidi/breaking-the-bridge-0ad349ac6614?source=rss-fe689d580173------2</link>
            <guid isPermaLink="false">https://medium.com/p/0ad349ac6614</guid>
            <category><![CDATA[nanotechnology]]></category>
            <category><![CDATA[alzheimers]]></category>
            <category><![CDATA[science]]></category>
            <category><![CDATA[brain]]></category>
            <category><![CDATA[neuroscience]]></category>
            <dc:creator><![CDATA[Upaasana Muppidi]]></dc:creator>
            <pubDate>Sat, 03 Jan 2026 00:30:11 GMT</pubDate>
            <atom:updated>2026-01-03T00:34:35.614Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/366/1*o31uLbLS2Mfwvchh2sfAng.png" /></figure><p>15–20% of the population has a gene that increases their risk of getting Alzheimer’s Disease by 3 times with one copy and 15 with a second! The R251G mutation erases this added chance of developing Alzheimer’s Disease in people with the ApoE4 gene with one simple amino acid switch at Codon 251. Despite changing so little, its effects are very beneficial. However, only 0.1% of the population has it. If a nanobot like the one I’m developing, <a href="https://medium.com/@urmuppidi/preventing-alzheimers-before-it-strikes-5ef2e3de5c7b">Nanny the Nanobot</a>, could mimic this variant, millions of people would not have to live in constant fear of developing Alzheimer’s Disease.</p><p>One key action is the disruption of a salt bridge built between Glu255 and Arg61. In ApoE4, this salt bridge connects the N and C terminal domains and makes the ApoE4’s structure very compact. Their interactions allow for amyloid-beta clumps and increase plaque formations, directly contributing to the development of Alzheimer’s Disease.</p><p>With the R251G mutation, these domains cannot communicate because the positively-charged arginine is replaced with the neutrally-charged glycine at codon 251. Therefore, there is no electrostatic network from Glu255 to Arg61, preventing the formation of a salt bridge. Without it, ApoE4 opens up and behaves more like ApoE3. The destruction of this salt bridge eliminates the harmful plaque buildup originally produced with ApoE4.</p><p>This will definitely be copied by Nanny. By neutralizing the positive charge of arginine at codon 251, similar to R251G, Nanny the Nanobot could destroy the salt bridge and open up the ApoE4 protein.</p><p>By researching ways to cancel out arginine’s charge at codon 251 and implementing them into Nanny’s design, I can “force” ApoE4 to stop producing harmful amyloid-beta plaques that damage synapses and disrupt communication between neurons. This will offer hope to the large population of people with a copy of ApoE4 by preventing the risk of AD’s development.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/684/1*gl9DeluxmZE3rVgWUjNUeg.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=0ad349ac6614" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Silent Thief]]></title>
            <link>https://medium.com/@urmuppidi/the-silent-thief-92b1f4430661?source=rss-fe689d580173------2</link>
            <guid isPermaLink="false">https://medium.com/p/92b1f4430661</guid>
            <category><![CDATA[nanotechnology]]></category>
            <category><![CDATA[neuroscience]]></category>
            <category><![CDATA[alzheimers]]></category>
            <dc:creator><![CDATA[Upaasana Muppidi]]></dc:creator>
            <pubDate>Thu, 23 Oct 2025 23:27:05 GMT</pubDate>
            <atom:updated>2025-10-23T23:27:05.703Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/418/1*TDJYVC9lLN1q1Zc7tcWtDg.png" /></figure><p>The threads snap slowly and gradually. Memories fade not with a crash, but a whisper.</p><p>It doesn’t happen all at once. It happens so subtly that you don’t notice. At first, they may just forget a name or special day. It could be forgetting a common word or recent conversation. Suddenly, it’s not so little anymore.</p><p>They forget how to brush their teeth or dress themselves. Conversations aren’t fun either. They’re withdrawn, frustrated, scared, and angry. You can’t help but wonder if they’re the same person that they once were. What really hurts though is when they forget you.</p><p>They forget your laughter and face. Those shared memories are now only remembered by you. You hold onto memories that can no longer be recited. It feels like you took those small, beautiful moments for granted before they changed forever.</p><p>Alzheimer’s Disease changes people forever. That is why it is so crucial to protect them.</p><p>Nanny the Nanobot will be a preventive tool against Alzheimer’s Disease. It will preserve the memories that are the strings that tie us to the people we love. As I mentioned in my first post, Nanny the Nanobot will replicate a protective genetic mutation to help prevent the development of Alzheimer’s Disease in those with the common gene, APOE4, that normally increases one’s risk of having the disease.</p><p>In protecting our memories, we protect our identities and the people who make them worth remembering. Please follow me as I try to solve this problem.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/428/1*6y408z10hChgCZXWLrg8kA.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=92b1f4430661" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Preventing Alzheimer’s Before It Strikes]]></title>
            <link>https://medium.com/@urmuppidi/preventing-alzheimers-before-it-strikes-5ef2e3de5c7b?source=rss-fe689d580173------2</link>
            <guid isPermaLink="false">https://medium.com/p/5ef2e3de5c7b</guid>
            <category><![CDATA[nanotechnology]]></category>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[alzheimers]]></category>
            <category><![CDATA[neuroscience]]></category>
            <category><![CDATA[science]]></category>
            <dc:creator><![CDATA[Upaasana Muppidi]]></dc:creator>
            <pubDate>Thu, 02 Oct 2025 23:16:25 GMT</pubDate>
            <atom:updated>2025-10-02T23:16:25.848Z</atom:updated>
            <content:encoded><![CDATA[<p>Nanny the Nanobot</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/564/1*r8osHf-Ns1cc-8Z2hHAi2Q.png" /></figure><p><em>“Memories are the invisible threads that keep us tied to the people we love”</em></p><p>Nanny the Nanobot is here to forestall Alzheimer’s Disease before it affects you and your loved ones. Designing and building a nanobot that can decrease the risk of one being diagnosed with Alzheimer’s Disease is needed now more than ever. With the amount of people affected increasing daily, there has to be a way to stop it. One of the most common genetic variants that can lead to having Alzheimer’s Disease is APOE4. One copy of APOE4 more than triples one’s chances of developing the disease, and two copies increases it by ten or more. Recently, a mutation to this gene, R251G, has been discovered. It shockingly reverses the negative effects of the APOE4 allele with a single protein switch from arginine to glycine. The only problem is that it is so rare that it is only found in less than 0.1% of the general population. If a nanobot could mimic this, surely that would help the whopping 25% of people that have a copy of the APOE4 allele.</p><p>Memories are one of our most prized possessions. They are intangible, so nobody can take them from you, and they are how you remember what is most precious and dear to you. They form our identities, beliefs, relationships, and decisions. Imagine forgetting the small but powerful moments that make up who you are. They may be that one encounter that led you to meet your closest friend, watching a loved one’s face light up with joy, the day of your wedding, laughing so hard your stomach hurts, or just being in the presence of family. Imagine waking up one day to not knowing your spouse, kids, or grandchildren. Everything would be gone, as if nothing ever happened. For millions, this is reality. The ever so deleterious Alzheimer’s Disease is capable of inflicting that horror to you and those around you.</p><p>Nanny the Nanobot will one day be able to cross the blood-brain barrier and mimic the R251G mutation, succoring those with a higher risk of having Alzheimer’s Disease. At this moment, my idea is to use a hydrogel coating for biocompatibility and magnetic particles for navigation and to create such a nanobot. One day, Nanny the Nanobot will protect our precious memories before Alzheimer’s Disease can seize them from us.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/396/1*ZxLbc6PPjsnp8K6ceY6s2g.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5ef2e3de5c7b" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>